3,4-dihydroxyphenylacetic acid has been researched along with Body Weight in 89 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "When the hypothalamic ventromedial nucleus and arcuate nucleus were destroyed in rats by treatment with monosodium glutamate in the neonatal stage, increase in the Lee index (body weight 1/3/body length) and in retroperitoneal fat as well as decreases in spontaneous motor activity, food consumption and growth hormone secretion function associated with hypothalamic low body length obesity (monosodium glutamate-treated obesity; MSG-OB) were observed as these rats grew." | 7.70 | Effects of chronic administration of sibutramine on body weight, food intake and motor activity in neonatally monosodium glutamate-treated obese female rats: relationship of antiobesity effect with monoamines. ( Gomita, Y; Nakagawa, T; Ohyama, T; Okamura, H; Ukai, K, 2000) |
| "We have established an animal model for olanzapine-induced body weight gain, and used it to explore the relation between this weight gain, excessive food consumption, gross motor activity, and macronutrient choice." | 3.72 | An animal model of antipsychotic-induced weight gain. ( Adamson, B; Arjona, AA; Wurtman, RJ; Zhang, SX, 2004) |
| "When the hypothalamic ventromedial nucleus and arcuate nucleus were destroyed in rats by treatment with monosodium glutamate in the neonatal stage, increase in the Lee index (body weight 1/3/body length) and in retroperitoneal fat as well as decreases in spontaneous motor activity, food consumption and growth hormone secretion function associated with hypothalamic low body length obesity (monosodium glutamate-treated obesity; MSG-OB) were observed as these rats grew." | 3.70 | Effects of chronic administration of sibutramine on body weight, food intake and motor activity in neonatally monosodium glutamate-treated obese female rats: relationship of antiobesity effect with monoamines. ( Gomita, Y; Nakagawa, T; Ohyama, T; Okamura, H; Ukai, K, 2000) |
| "Intracerebral microdialysis was applied to monitor the neocortical extracellular levels of the aromatic amino acids phenylalanine, tyrosine, and tryptophan, the neurotransmitters dopamine (DA), noradrenaline (NA), and serotonin (5-HT), and the metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and 5-hydroxyindole-3-acetic acid (5-HIAA) in rats with various forms of experimental hepatic encephalopathy (HE)." | 3.69 | Neocortical dialysate monoamines of rats after acute, subacute, and chronic liver shunt. ( Bengtsson, F; Bergqvist, PB; Bosman, DK; Chamuleau, RA; Hjorth, S; Maas, MA; Vogels, BA, 1995) |
| "Phenelzine (PLZ), a nonselective monoamine oxidase inhibitor, is widely used in psychiatry for the treatment of panic disorder and depression." | 3.68 | Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines, and alpha 2-adrenoreceptor function. ( Baker, GB; Coutts, RT; Greenshaw, AJ; McKenna, KF, 1992) |
| "This study on the role of the sympathetic nervous system in the development of hypertension involves the measurement of dopamine and norepinephrine accumulation in various tissues of the hypertensive and random-bred normotensive strains of mice at basal levels, and following a pargyline-L-dopa treatment." | 3.67 | L-dopa metabolism in genetically hypertensive mice: effect of pargyline. ( Buu, NT; Duhaime, J; Kuchel, O; Racz, K; Schlager, G, 1987) |
| " However, evidence indicates that exposure to toxic doses of MDMA can lead to long-lasting dysregulation of brain monoaminergic neurotransmitters, primarily from studies conducted in young adult rodents." | 1.56 | The acute toxic and neurotoxic effects of 3,4-methylenedioxymethamphetamine are more pronounced in adolescent than adult mice. ( Bagwell, MS; Chitre, NM; Murnane, KS, 2020) |
| "Thus, overnutrition due to fats may be central to childhood psychological perturbations such as anxiety and ADHD." | 1.39 | Methylphenidate prevents high-fat diet (HFD)-induced learning/memory impairment in juvenile mice. ( Chiu, GS; Freund, GG; Gainey, SJ; Kaczmarczyk, MM; Kelley, KW; Kwakwa, KA; Lawson, MA; Machaj, AS; Martin, SA; Meling, DD; Miller, MJ; Newman, AF; Wang, Y; Woods, JA; York, JM, 2013) |
| "The combined decrease in Ago2 and increases in Nurr1 and Pitx3 might represent some of the mechanisms that served to protect against accumbal TH regulation observed in morphine withdrawn rats, which may be critical for DA bioavailability to influence behaviour." | 1.39 | Morphine administration modulates expression of Argonaute 2 and dopamine-related transcription factors involved in midbrain dopaminergic neurons function. ( García-Pérez, D; Laorden, ML; Milanés, MV; Núñez, C; Sáez-Belmonte, F, 2013) |
| "However, 6-h sleep deprivation caused the recovery of the delta power in VAD mice to a level similar to that of the control." | 1.34 | Vitamin A deficiency induces a decrease in EEG delta power during sleep in mice. ( Chikahisa, S; Hattori, A; Kitaoka, K; Miyamoto, K; Nakaya, Y; Sei, H, 2007) |
| "Treatment with imipramine (10mg/kg i." | 1.33 | Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains. ( Antoniou, K; Bekris, S; Daskas, S; Papadopoulou-Daifoti, Z, 2005) |
| " In electrophysiology studies, acute administration of FMPD selectively elevated the number of spontaneously active A10 (versus A9) dopamine neurons and chronic administration selectively decreased the number of spontaneously active A10 (versus A9) dopamine neurons." | 1.33 | Preclinical pharmacology of FMPD [6-fluoro-10-[3-(2-methoxyethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene]: a potential novel antipsychotic with lower histamine H1 receptor affinity than olanzapine. ( Benvenga, MJ; Bymaster, FP; Calligaro, DO; Cohen, IR; Falcone, JF; Hemrick-Luecke, SK; Martin, FM; Moore, NA; Nelson, DL; Nisenbaum, LK; Rasmussen, K; Schaus, JM; Sundquist, SJ; Tupper, DE; Wiernicki, TR, 2005) |
| "Reactive gliosis occurred only in response to combined PQ + MB in dorsal-medial but not ventral striatum." | 1.31 | The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease. ( Baggs, RB; Cory-Slechta, DA; Richfield, EK; Tank, AW; Thiruchelvam, M, 2000) |
| " A treatment history of high AMPH dosage was associated with a marked sensitization of the exploratory behavior in adults, whereas it induced a quite opposite profile in periadolescents." | 1.31 | Striatal dopamine sensitization to D-amphetamine in periadolescent but not in adult rats. ( Laviola, G; Pascucci, T; Pieretti, S, 2001) |
| " PHEN also significantly enhanced FEN's long-term toxic effects on 5-HT axons." | 1.30 | Neurotoxic effects of +/-fenfluramine and phenteramine, alone and in combination, on monoamine neurons in the mouse brain. ( McCann, UD; Ricaurte, GA; Yuan, J, 1998) |
| "Carbaryl and aldicarb were injected in ovo on day 15 of incubation at 6, 16 and 65 mg kg-1 egg weight and at 0." | 1.28 | Chick embryo exposure to carbamates alters neurochemical parameters and behavior. ( Blaker, WD; Farage-Elawar, M, 1992) |
| "(-)-Nicotine was administered for 7 days using subcutaneously implanted nicotine releasing reservoirs." | 1.28 | Chronic nicotine treatment changes differentially the effects of acute nicotine on the three main dopamine metabolites in mouse striatum. ( Ahtee, L; Heinämäki, J; Laakso, I; Leikola-Pelho, T, 1990) |
| "Buspirone is a novel anti-anxiety drug which has neither a benzodiazepine structure nor any other benzodiazepine-like properties." | 1.27 | Comparative chronic effects of buspirone or neuroleptics on rat brain dopaminergic neurotransmission. ( McMillen, BA, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (19.10) | 18.7374 |
| 1990's | 27 (30.34) | 18.2507 |
| 2000's | 33 (37.08) | 29.6817 |
| 2010's | 11 (12.36) | 24.3611 |
| 2020's | 1 (1.12) | 2.80 |
| Authors | Studies |
|---|---|
| Chitre, NM | 1 |
| Bagwell, MS | 1 |
| Murnane, KS | 1 |
| Kaczmarczyk, MM | 1 |
| Machaj, AS | 1 |
| Chiu, GS | 1 |
| Lawson, MA | 1 |
| Gainey, SJ | 1 |
| York, JM | 1 |
| Meling, DD | 1 |
| Martin, SA | 1 |
| Kwakwa, KA | 1 |
| Newman, AF | 1 |
| Woods, JA | 1 |
| Kelley, KW | 1 |
| Wang, Y | 1 |
| Miller, MJ | 1 |
| Freund, GG | 1 |
| Huang, Y | 1 |
| Chen, S | 1 |
| Xu, H | 1 |
| Yu, X | 1 |
| Lai, H | 1 |
| Ho, G | 1 |
| Huang, Q | 1 |
| Shi, X | 1 |
| van Heesch, F | 1 |
| Prins, J | 1 |
| Korte-Bouws, GA | 2 |
| Westphal, KG | 1 |
| Lemstra, S | 1 |
| Olivier, B | 1 |
| Kraneveld, AD | 1 |
| Korte, SM | 2 |
| Pannia, E | 1 |
| Cho, CE | 1 |
| Kubant, R | 1 |
| Sánchez-Hernández, D | 1 |
| Huot, PS | 1 |
| Chatterjee, D | 1 |
| Fleming, A | 1 |
| Anderson, GH | 1 |
| Papoutsoglou, SE | 1 |
| Karakatsouli, N | 1 |
| Psarrou, A | 1 |
| Apostolidou, S | 1 |
| Papoutsoglou, ES | 1 |
| Batzina, A | 1 |
| Leondaritis, G | 1 |
| Sakellaridis, N | 1 |
| Ardis, TC | 1 |
| Cahir, M | 1 |
| Elliott, JJ | 1 |
| Bell, R | 1 |
| Reynolds, GP | 1 |
| Cooper, SJ | 1 |
| Ling, Z | 1 |
| Zhu, Y | 1 |
| Tong, CW | 1 |
| Snyder, JA | 1 |
| Lipton, JW | 1 |
| Carvey, PM | 1 |
| Verhagen, LA | 1 |
| Luijendijk, MC | 1 |
| Adan, RA | 1 |
| Darvas, M | 1 |
| Palmiter, RD | 1 |
| Oyama, G | 1 |
| Yoshimi, K | 1 |
| Natori, S | 1 |
| Chikaoka, Y | 1 |
| Ren, YR | 1 |
| Funayama, M | 1 |
| Shimo, Y | 1 |
| Takahashi, R | 1 |
| Nakazato, T | 1 |
| Kitazawa, S | 1 |
| Hattori, N | 1 |
| Tsai, SJ | 1 |
| Chao, CY | 1 |
| Yin, MC | 1 |
| Wey, MC | 1 |
| Fernandez, E | 1 |
| Martinez, PA | 1 |
| Sullivan, P | 1 |
| Goldstein, DS | 1 |
| Strong, R | 1 |
| García-Pérez, D | 1 |
| Sáez-Belmonte, F | 1 |
| Laorden, ML | 2 |
| Núñez, C | 1 |
| Milanés, MV | 2 |
| Waters, RP | 1 |
| Pringle, RB | 1 |
| Forster, GL | 1 |
| Renner, KJ | 1 |
| Malisch, JL | 1 |
| Garland, T | 1 |
| Swallow, JG | 1 |
| Gehrke, BJ | 1 |
| Harrod, SB | 1 |
| Cass, WA | 1 |
| Bardo, MT | 1 |
| Crawford, CA | 1 |
| Williams, MT | 1 |
| Newman, ER | 1 |
| McDougall, SA | 1 |
| Vorhees, CV | 1 |
| Antkiewicz-Michaluk, L | 1 |
| Karolewicz, B | 1 |
| Romańska, I | 1 |
| Michaluk, J | 1 |
| Bojarski, AJ | 1 |
| Vetulani, J | 1 |
| Sampaio-Maia, B | 1 |
| Serrão, P | 1 |
| Vieira-Coelho, MA | 1 |
| Pestana, M | 1 |
| Michna, L | 1 |
| Lu, YP | 1 |
| Lou, YR | 1 |
| Wagner, GC | 1 |
| Conney, AH | 1 |
| Dietz, DM | 1 |
| Pletnikov, MV | 1 |
| Arjona, AA | 1 |
| Zhang, SX | 1 |
| Adamson, B | 1 |
| Wurtman, RJ | 1 |
| Saito, S | 1 |
| Takagi, T | 1 |
| Koutoku, T | 1 |
| Saito, ES | 1 |
| Hirakawa, H | 1 |
| Tomonaga, S | 1 |
| Tachibana, T | 1 |
| Denbow, DM | 1 |
| Furuse, M | 1 |
| Bekris, S | 1 |
| Antoniou, K | 1 |
| Daskas, S | 1 |
| Papadopoulou-Daifoti, Z | 1 |
| Wieczorek, M | 1 |
| Swiergiel, AH | 1 |
| Pournajafi-Nazarloo, H | 1 |
| Dunn, AJ | 1 |
| Taysse, L | 1 |
| Christin, D | 1 |
| Delamanche, S | 1 |
| Bellier, B | 1 |
| Breton, P | 1 |
| Rasmussen, K | 1 |
| Benvenga, MJ | 1 |
| Bymaster, FP | 1 |
| Calligaro, DO | 1 |
| Cohen, IR | 1 |
| Falcone, JF | 1 |
| Hemrick-Luecke, SK | 1 |
| Martin, FM | 1 |
| Moore, NA | 1 |
| Nisenbaum, LK | 1 |
| Schaus, JM | 1 |
| Sundquist, SJ | 1 |
| Tupper, DE | 1 |
| Wiernicki, TR | 1 |
| Nelson, DL | 1 |
| Yim, AJ | 1 |
| Miranda-Paiva, CM | 1 |
| Flório, JC | 1 |
| Oliveira, CA | 1 |
| Nasello, AG | 1 |
| Felicio, LF | 1 |
| Oida, Y | 1 |
| Kitaichi, K | 1 |
| Nakayama, H | 1 |
| Ito, Y | 1 |
| Fujimoto, Y | 1 |
| Shimazawa, M | 1 |
| Nagai, H | 1 |
| Hara, H | 1 |
| Tsunoda, M | 1 |
| Aizawa, Y | 1 |
| Konno, N | 1 |
| Kimura, K | 1 |
| Sugita-Konishi, Y | 1 |
| Song, C | 1 |
| Li, X | 1 |
| Kang, Z | 1 |
| Kadotomi, Y | 1 |
| Hellweg, R | 1 |
| Zueger, M | 1 |
| Fink, K | 1 |
| Hörtnagl, H | 1 |
| Gass, P | 1 |
| Mayer, MA | 1 |
| Höcht, C | 1 |
| Opezzo, JA | 1 |
| Peredo, HA | 1 |
| Navacchia, D | 1 |
| Taira, CA | 1 |
| Fernández, BE | 1 |
| Puyó, AM | 1 |
| Kitaoka, K | 1 |
| Hattori, A | 1 |
| Chikahisa, S | 1 |
| Miyamoto, K | 1 |
| Nakaya, Y | 1 |
| Sei, H | 1 |
| Anderzhanova, E | 1 |
| Covasa, M | 1 |
| Hajnal, A | 1 |
| Baldwin, CM | 1 |
| Figueredo, AJ | 1 |
| Wright, LS | 1 |
| Wong, SS | 1 |
| Witten, ML | 1 |
| Davidson, C | 1 |
| Chen, Q | 2 |
| Zhang, X | 1 |
| Xiong, X | 1 |
| Lazarus, C | 1 |
| Lee, TH | 1 |
| Ellinwood, EH | 1 |
| Lavi-Avnon, Y | 1 |
| Weller, A | 1 |
| Finberg, JP | 1 |
| Gispan-Herman, I | 1 |
| Kinor, N | 1 |
| Stern, Y | 1 |
| Schroeder, M | 1 |
| Gelber, V | 1 |
| Bergman, SY | 1 |
| Overstreet, DH | 1 |
| Yadid, G | 1 |
| Clow, A | 1 |
| Theodorou, A | 1 |
| Jenner, P | 2 |
| Marsden, CD | 2 |
| Govoni, S | 1 |
| Memo, M | 1 |
| Lucchi, L | 1 |
| Spano, PF | 1 |
| Trabucchi, M | 1 |
| Hall, MD | 1 |
| Cooper, DR | 1 |
| Fleminger, S | 1 |
| Rupniak, NM | 1 |
| Cuomo, V | 1 |
| Cagiano, R | 1 |
| Coen, E | 1 |
| Mocchetti, I | 1 |
| Cattabeni, F | 1 |
| Racagni, G | 1 |
| Cottet-Emard, JM | 1 |
| Peyrin, L | 1 |
| Bonnod, J | 1 |
| Beard, JL | 1 |
| Connor, J | 1 |
| Jones, BC | 1 |
| Bergqvist, PB | 1 |
| Vogels, BA | 1 |
| Bosman, DK | 1 |
| Maas, MA | 1 |
| Hjorth, S | 1 |
| Chamuleau, RA | 1 |
| Bengtsson, F | 1 |
| Bourson, A | 1 |
| Borroni, E | 1 |
| Austin, RH | 1 |
| Monsma, FJ | 1 |
| Sleight, AJ | 1 |
| Castaño, A | 1 |
| Herrera, AJ | 1 |
| Cano, J | 3 |
| Machado, A | 3 |
| Yamada, T | 1 |
| Nakamura, J | 1 |
| Murakami, M | 1 |
| Okuno, Y | 1 |
| Hosokawa, S | 1 |
| Matsuo, M | 1 |
| Yamada, H | 1 |
| Vizuete, ML | 1 |
| Steffen, V | 1 |
| Parhar, IS | 1 |
| Sim, MK | 1 |
| Frankmann, SP | 1 |
| Broder, L | 1 |
| Dokko, JH | 1 |
| Smith, GP | 2 |
| Jensen, EW | 1 |
| Eldrup, E | 1 |
| Kelbaek, H | 1 |
| Nielsen, SL | 1 |
| Christensen, NJ | 1 |
| Middaugh, LD | 1 |
| Boggan, WO | 1 |
| Bingel, SA | 1 |
| Patrick, KS | 1 |
| Xu, W | 1 |
| Revuelta, M | 1 |
| Romero-Ramos, M | 1 |
| Venero, JL | 1 |
| Millan, F | 1 |
| Seegal, RF | 2 |
| Brosch, KO | 2 |
| Okoniewski, RJ | 1 |
| Rybkin, II | 1 |
| Zhou, Y | 1 |
| Volaufova, J | 1 |
| Smagin, GN | 1 |
| Ryan, DH | 1 |
| Harris, RB | 1 |
| Zecca, L | 1 |
| Mantegazza, C | 1 |
| Margonato, V | 1 |
| Cerretelli, P | 1 |
| Caniatti, M | 1 |
| Piva, F | 1 |
| Dondi, D | 1 |
| Hagino, N | 1 |
| McCann, UD | 1 |
| Yuan, J | 1 |
| Ricaurte, GA | 1 |
| ThyagaRajan, S | 1 |
| Quadri, SK | 1 |
| Fuertes, G | 1 |
| Nakagawa, T | 1 |
| Ukai, K | 1 |
| Ohyama, T | 1 |
| Gomita, Y | 1 |
| Okamura, H | 1 |
| Thiruchelvam, M | 1 |
| Richfield, EK | 1 |
| Baggs, RB | 1 |
| Tank, AW | 1 |
| Cory-Slechta, DA | 1 |
| Laviola, G | 1 |
| Pascucci, T | 1 |
| Pieretti, S | 1 |
| Rossi, J | 1 |
| Nordholm, AF | 1 |
| Carpenter, RL | 1 |
| Ritchie, GD | 1 |
| Malcomb, W | 1 |
| Kalinski, MI | 1 |
| Dluzen, DE | 1 |
| Stadulis, R | 1 |
| Rebec, GV | 1 |
| Barton, SJ | 1 |
| Ennis, MD | 1 |
| Rastogi, RB | 1 |
| Lapierre, YD | 1 |
| Singhal, RL | 1 |
| Awazi, N | 1 |
| Guldberg, HC | 1 |
| Farage-Elawar, M | 1 |
| Blaker, WD | 1 |
| McKenna, KF | 1 |
| Baker, GB | 1 |
| Coutts, RT | 1 |
| Greenshaw, AJ | 1 |
| Jones, GH | 1 |
| Hernandez, TD | 1 |
| Kendall, DA | 1 |
| Marsden, CA | 1 |
| Robbins, TW | 1 |
| Orosco, M | 2 |
| Rouch, C | 2 |
| Gripois, D | 2 |
| Blouquit, MF | 2 |
| Roffi, J | 2 |
| Jacquot, C | 2 |
| Cohen, Y | 2 |
| Schechter, LE | 1 |
| Bolaños, FJ | 1 |
| Gozlan, H | 1 |
| Lanfumey, L | 1 |
| Haj-Dahmane, S | 1 |
| Laporte, AM | 1 |
| Fattaccini, CM | 1 |
| Hamon, M | 1 |
| Hirose, T | 1 |
| Bush, B | 1 |
| Vaccari, A | 1 |
| Rossetti, ZL | 1 |
| de Montis, G | 1 |
| Stefanini, E | 1 |
| Martino, E | 1 |
| Gessa, GL | 1 |
| Leikola-Pelho, T | 1 |
| Heinämäki, J | 1 |
| Laakso, I | 1 |
| Ahtee, L | 1 |
| Winn, P | 1 |
| Clark, A | 1 |
| Hastings, M | 1 |
| Clark, J | 1 |
| Latimer, M | 1 |
| Rugg, E | 1 |
| Brownlee, B | 1 |
| Coulombe, RA | 1 |
| Sharma, RP | 1 |
| Fride, E | 1 |
| Weinstock, M | 1 |
| Fung, YK | 1 |
| Lau, YS | 1 |
| McMillen, BA | 1 |
| Magnusson, O | 1 |
| Mohringe, B | 1 |
| Thorell, G | 1 |
| Lake-Bakaar, DM | 1 |
| Buu, NT | 1 |
| Duhaime, J | 1 |
| Racz, K | 1 |
| Kuchel, O | 1 |
| Schlager, G | 1 |
| Chance, WT | 1 |
| Foley-Nelson, T | 1 |
| Nelson, JL | 1 |
| Fischer, JE | 1 |
| Guilarte, TR | 1 |
| Wagner, HN | 1 |
| Frost, JJ | 1 |
| Sedlock, ML | 1 |
| Ravitch, J | 1 |
| Edwards, DJ | 1 |
| Simansky, KJ | 1 |
| Bourbonais, KA | 1 |
1 trial available for 3,4-dihydroxyphenylacetic acid and Body Weight
| Article | Year |
|---|---|
Gilthead seabream (Sparus aurata) response to three music stimuli (Mozart--"Eine Kleine Nachtmusik," Anonymous--"Romanza," Bach--"Violin Concerto No. 1") and white noise under recirculating water conditions.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acoustic Stimulation; Adipose Tissue; Analysis of Variance; Animals; | 2015 |
88 other studies available for 3,4-dihydroxyphenylacetic acid and Body Weight
| Article | Year |
|---|---|
The acute toxic and neurotoxic effects of 3,4-methylenedioxymethamphetamine are more pronounced in adolescent than adult mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Animals; Body Weight; Central Nervous System Stimulants | 2020 |
Methylphenidate prevents high-fat diet (HFD)-induced learning/memory impairment in juvenile mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents; Anxiety; Blood Glucose; Body Weight; | 2013 |
Pre-gestational stress alters stress-response of pubertal offspring rat in sexually dimorphic and hemispherically asymmetric manner.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Animals, Newborn; Body Weight; Catech | 2013 |
Systemic tumor necrosis factor-alpha decreases brain stimulation reward and increases metabolites of serotonin and dopamine in the nucleus accumbens of mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Affect; Animals; Body Weight; Brain; Dopamine; Electric Stimulation; | 2013 |
A high multivitamin diet fed to Wistar rat dams during pregnancy increases maternal weight gain later in life and alters homeostatic, hedonic and peripheral regulatory systems of energy balance.
Topics: 3,4-Dihydroxyphenylacetic Acid; Abdominal Fat; Age Factors; Animals; Animals, Newborn; Body Weight; | 2015 |
Effect of acute tryptophan depletion on noradrenaline and dopamine in the rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amino Acids, Essential; Animals; Body Weight; Brain Chemistry; Corpu | 2009 |
Prenatal lipopolysaccharide does not accelerate progressive dopamine neuron loss in the rat as a result of normal aging.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Aging; Analysis of Variance; Animals; Body Weight; Brai | 2009 |
Dopamine and serotonin release in the nucleus accumbens during starvation-induced hyperactivity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Body Temperature; Body Weight; Chroma | 2009 |
Restricting dopaminergic signaling to either dorsolateral or medial striatum facilitates cognition.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Body Weight; Cognition; Conditioning, Ope | 2010 |
Impaired in vivo dopamine release in parkin knockout mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Body Weight; Corpus Striatum; Dopamine; Homovanillic | 2010 |
Preventive and therapeutic effects of caffeic acid against inflammatory injury in striatum of MPTP-treated mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Weight; Brain-Derived Neurotrophic Factor; Caffeic Aci | 2011 |
Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehyde Dehydrogenase; Animals; Body Weight; Cognition Disorders; C | 2012 |
Morphine administration modulates expression of Argonaute 2 and dopamine-related transcription factors involved in midbrain dopaminergic neurons function.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Argonaute Proteins; Body Weight; Dopamine; Drug Implants; G | 2013 |
Selection for increased voluntary wheel-running affects behavior and brain monoamines in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Behavior, Animal; Biogenic Monoamines | 2013 |
The effect of neurotoxic doses of methamphetamine on methamphetamine-conditioned place preference in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Temperature; Body Weight; Brain Chemistry; Central Ner | 2003 |
Methamphetamine exposure during the preweanling period causes prolonged changes in dorsal striatal protein kinase A activity, dopamine D2-like binding sites, and dopamine content.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Animals, Newborn; Binding Sites; Binding, Competitive; Body | 2003 |
1-methyl-1,2,3,4-tetrahydroisoquinoline protects against rotenone-induced mortality and biochemical changes in rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Weight; Brain; Corpus Striatum; Dopamine; Dopamine Ant | 2003 |
Differences in the renal dopaminergic system activity between Wistar rats from two suppliers.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Aromatic-L-Amino-Acid Decarboxylases; Blood Pressure; Body | 2003 |
Stimulatory effect of oral administration of green tea and caffeine on locomotor activity in SKH-1 mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adipose Tissue; Animals; Body Weight; Brain Chemistry; Caffeine; Dop | 2003 |
Postnatal weight gain inhibition does not account for neurobehavioral consequences of neonatal Borna disease virus infection.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Analysis of Variance; Animals; Animals, Newborn; Behavior, An | 2003 |
An animal model of antipsychotic-induced weight gain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Anima | 2004 |
Differences in catecholamine metabolism and behaviour in neonatal broiler and layer chicks.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Body Weight; Brain; Catecholamines; Chickens; Dopami | 2004 |
Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Beh | 2005 |
Physiological and behavioral responses to interleukin-1beta and LPS in vagotomized mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenocorticotropic Hormone; Analysis of Variance; Animals; Behavior | 2005 |
Peripheral ChE inhibition modulates brain monoamines levels and c-fos oncogene in mice subjected to a stress situation.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Body Weight; Brain Chemistry; Cholines | 2005 |
Preclinical pharmacology of FMPD [6-fluoro-10-[3-(2-methoxyethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene]: a potential novel antipsychotic with lower histamine H1 receptor affinity than olanzapine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Benzodiazepines; Body Weight; Catalep | 2005 |
A comparative study of morphine treatment regimen prior to mating and during late pregnancy.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Behavior, Animal; Body Weight; Brain | 2006 |
Rifampicin attenuates the MPTP-induced neurotoxicity in mouse brain.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; | 2006 |
Subacute administration of tributyltin chloride modulates neurotransmitters and their metabolites in discrete brain regions of maternal mice and their F1 offspring.
Topics: 3,4-Dihydroxyphenylacetic Acid; Administration, Oral; Animals; Animals, Newborn; Body Weight; Brain; | 2006 |
Omega-3 fatty acid ethyl-eicosapentaenoate attenuates IL-1beta-induced changes in dopamine and metabolites in the shell of the nucleus accumbens: involved with PLA2 activity and corticosterone secretion.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Body Weight; Corticosterone; Dinopros | 2007 |
Olfactory bulbectomy in mice leads to increased BDNF levels and decreased serotonin turnover in depression-related brain areas.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Body Weight; Brain Chemistry; Brain-Deriv | 2007 |
Role of hypothalamic alpha-adrenoceptor activity in fructose-induced hypertension.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anterior Hypothalamic Nucleus; Antibody Formation; Blood Pr | 2006 |
Vitamin A deficiency induces a decrease in EEG delta power during sleep in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Behavior, Animal; Body Weight; Corpus | 2007 |
Altered basal and stimulated accumbens dopamine release in obese OLETF rats as a function of age and diabetic status.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Animals; Body Weight; Diabetes Mellitus, Type 2; Dopami | 2007 |
Repeated aerosol-vapor JP-8 jet fuel exposure affects neurobehavior and neurotransmitter levels in a rat model.
Topics: 3,4-Dihydroxyphenylacetic Acid; Administration, Inhalation; Aerosols; Air Pollutants, Occupational; | 2007 |
Deprenyl treatment attenuates long-term pre- and post-synaptic changes evoked by chronic methamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Blotting, Western; Body Weight; Cauda | 2007 |
The reward system and maternal behavior in an animal model of depression: a microdialysis study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Animals; Animals, Newborn; Behavior, Animal; Body Weigh | 2008 |
Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenylyl Cyclases; Animals; Antipsychotic Agents; Apomorphine; Bindi | 1980 |
Brain neurotransmitter system and chronic lead intoxication.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Weight; Brain; Cyclic GMP; Female; gamma-Aminobutyric | 1980 |
Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenylyl Cyclases; Animals; Apomorphine; Behavior, Animal; Body Weig | 1984 |
Enduring behavioural and biochemical effects in the adult rat after prolonged postnatal administration of haloperidol.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Body Weight; Brain Chemistry; Female; Hal | 1981 |
Dietary induced changes in catecholamine metabolites in rat urine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amines; Animals; Blood Glucose; Body Weight; Catecholamines; Creatin | 1980 |
Altered monamine metabolism in caudate-putamen of iron-deficient rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Body Weight; Caudate Nucleus; Diet; Ho | 1994 |
Neocortical dialysate monoamines of rats after acute, subacute, and chronic liver shunt.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acute Disease; Amino Acids; Ammonia; Animals; Biogenic Monoamines; B | 1995 |
Determination of the role of the 5-ht6 receptor in the rat brain: a study using antisense oligonucleotides.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Atropine; Base Sequence; Body Temperature; Body Weight; Bra | 1995 |
Effects of a short period of vitamin E-deficient diet in the turnover of different neurotransmitters in substantia nigra and striatum of the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Weight; Corpus Striatum; Dendrites; Diet; Dopamine; Ea | 1993 |
Effect of chronic L-dopa administration on serum luteinizing hormone levels in male rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Weight; Hypothalamus; Levodopa; Luteinizing Hormone; M | 1995 |
1-Methyl-4-phenylpyridinium has greater neurotoxic effect after selenium deficiency than after vitamin E deficiency in rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Weight; Dopamine; Eating; Free Radicals; Glutathione P | 1994 |
Central dopaminergic neurons in tilapia: effects of gonadectomy and hypothalamic lesion.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Weight; Dopamine; Estrogens; Hypothalamus; Hypothalamu | 1994 |
Differential changes in central monoaminergic metabolism during first and multiple sodium depletions in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Body Weight; Brain Chemistry; Chromato | 1994 |
Venous plasma noradrenaline increases with age: correlation to total blood volume and long-term smoking habits.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Aged, 80 and over; Aging; Benserazide; Blood Volume; Bo | 1993 |
A murine model of prenatal cocaine exposure: effects on the mother and the fetus.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animal Nutritional Physiological Phenomena; Animals; Behavior, Anima | 1996 |
Less induced 1-methyl-4-phenylpyridinium ion neurotoxicity on striatal slices from guinea-pigs fed with a vitamin C-deficient diet.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Amino Acids; Animals; Ascorbic Acid Def | 1997 |
Effects of in utero and lactational exposure of the laboratory rat to 2,4,2',4'- and 3,4,3',4'-tetrachlorobiphenyl on dopamine function.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Weight; Brain Chemistry; Dopamine; Dose-Response Relat | 1997 |
Effect of restraint stress on food intake and body weight is determined by time of day.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adipose Tissue; Animals; Biogenic Monoamines; Body Weight; Brain Ste | 1997 |
Biological effects of prolonged exposure to ELF electromagnetic fields in rats: III. 50 Hz electromagnetic fields.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amines; Body Weight; Brain; Dopamine; Dose-Respons | 1998 |
Neurotoxic effects of +/-fenfluramine and phenteramine, alone and in combination, on monoamine neurons in the mouse brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Appetite Depressants; Biogenic Monoamines; Body Weight; Bra | 1998 |
L-deprenyl inhibits tumor growth, reduces serum prolactin, and suppresses brain monoamine metabolism in rats with carcinogen-induced mammary tumors.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Body Weight; Brain; Dopamine; Eating; | 1999 |
Noradrenergic and dopaminergic activity in the hypothalamic paraventricular nucleus after naloxone-induced morphine withdrawal.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Behavior, Animal; Body Weight; Chroni | 2000 |
Effects of chronic administration of sibutramine on body weight, food intake and motor activity in neonatally monosodium glutamate-treated obese female rats: relationship of antiobesity effect with monoamines.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adipose Tissue; Animals; Animals, Newborn; Appetite Depressants; Arc | 2000 |
The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Weight; Carrier Proteins; Cell Count; Corpus Striatum; | 2000 |
Striatal dopamine sensitization to D-amphetamine in periadolescent but not in adult rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Behavior, Animal; Body Weight; Brain Chemistry; Caud | 2001 |
Effects of repeated exposure of rats to JP-5 or JP-8 jet fuel vapor on neurobehavioral capacity and neurotransmitter levels.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Avoidance Learning; Behavior, Animal; Body Weight; Brain; D | 2001 |
Methamphetamine produces subsequent reductions in running time to exhaustion in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Weight; Cardiovascular Physiological Phenomena; Dopami | 2001 |
Dysregulation of ascorbate release in the striatum of behaving mice expressing the Huntington's disease gene.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Ascorbic Acid; Behavior, Animal; Body Weight; Corpus Striat | 2002 |
Evidence for the role of brain norepinephrine and dopamine in "rebound" phenomenon seen during withdrawal after repeated exposure to benzodiazepines.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Anxiety Agents; Body Weight; Brain; Brain Chemistry; B | 1977 |
On the interaction of 5-hydroxytryptophan and 5-hydroxytryptamine with dopamine metabolism in the rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Animals; Body Temperature; Body Weight; Brain C | 1978 |
Chick embryo exposure to carbamates alters neurochemical parameters and behavior.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aldicarb; Animals; Body Weight; Brain; Carbaryl; Chick Embryo; Chick | 1992 |
Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines, and alpha 2-adrenoreceptor function.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents; Biogenic Amines; Body Weight; Brain; | 1992 |
Dopaminergic and serotonergic function following isolation rearing in rats: study of behavioural responses and postmortem and in vivo neurochemistry.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Behavior, Animal; Body Weight; Brain Chemistry | 1992 |
Striatal dopamine metabolism is differentially affected by insulin according to the genotype in Zucker rats: a microdialysis study.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5-Methoxytryptamine; Animals; Body Weight; Corpus Striatum; Dopamine | 1992 |
Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Adenyly | 1990 |
[Effects of ethanol and low-carbohydrate diet on contents of noradrenaline, dopamine, serotonin and their metabolites in rat brain].
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Weight; Brain; Diet; Dietary Carbohydrates; Dopamine; | 1991 |
Effects of insulin on brain monoamine metabolism in the Zucker rat: influence of genotype and age.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Animals; Biogenic Monoamines; Blood Glucose; Body Weigh | 1991 |
Comparison of effects of Aroclors 1016 and 1260 on non-human primate catecholamine function.
Topics: 3,4-Dihydroxyphenylacetic Acid; Administration, Oral; Animals; Aroclors; Body Weight; Brain; Brain C | 1991 |
Neonatal hypothyroidism induces striatal dopaminergic dysfunction.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Animals, Newborn; Benzazepines; Body Weight; Corpus Striatu | 1990 |
Chronic nicotine treatment changes differentially the effects of acute nicotine on the three main dopamine metabolites in mouse striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Temperature; Body Weight; Corpus Striatum; Cotinine; D | 1990 |
Excitotoxic lesions of the lateral hypothalamus made by N-methyl-d-aspartate in the rat: behavioural, histological and biochemical analyses.
Topics: 3,4-Dihydroxyphenylacetic Acid; Angiotensin II; Animals; Body Weight; Corpus Striatum; Deoxyglucose; | 1990 |
Effect of repeated dietary exposure of aflatoxin B1 on brain biogenic amines and metabolites in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aflatoxin B1; Aflatoxins; Animals; Biogenic Amines; Body Weight; Bra | 1985 |
Alterations in behavioral and striatal dopamine asymmetries induced by prenatal stress.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Behavior, Animal; Body Weight; Caudate Nucleus | 1989 |
Effects of prenatal nicotine exposure on rat striatal dopaminergic and nicotinic systems.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Weight; Corpus Striatum; Cotinine; Female; Gestational | 1989 |
Comparative chronic effects of buspirone or neuroleptics on rat brain dopaminergic neurotransmission.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Anxiety Agents; Antipsychotic Agents; Body Weight; Bus | 1985 |
Effects of the dopamine D2 selective receptor antagonist remoxipride on dopamine turnover in the rat brain after acute and repeated administration.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Benzamides; Body Weight; Brain Chemis | 1987 |
L-dopa metabolism in genetically hypertensive mice: effect of pargyline.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Weight; Brain; Dopamine; Dopamine beta-Hydroxylase; Dr | 1987 |
Neurotransmitter alterations associated with feeding and satiety.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Blood Glucose; Body Weight; Brain; Catecholamines; Feeding | 1987 |
Effects of perinatal vitamin B6 deficiency on dopaminergic neurochemistry.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Weight; Chromatography, High Pressure Liquid; Corpus S | 1987 |
The effect of dietary precursors on the excretion of amines and their metabolites in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amines; Animals; Body Weight; Brain Chemistry; Catecholamines; Chrom | 1985 |
Food-related stimuli increase the ratio of 3,4-dihydroxyphenylacetic acid to dopamine in the hypothalamus.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Weight; Dopamine; Drinking; Food; Food Deprivation; Hy | 1985 |